129 results
Page 2 of 7
6-K
EX-99.2
ysnuqwluxpicvg8zzceb
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
5q3se44t8qj5c01l z2
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
8oqfxkm9mguu 4l9rg7
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
g0n9p
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
zwt emr573433w
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.4
j2cltjq0a8 ncxgk3y
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
sqfbte zqz61
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
sashi445k
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
ah5zg2nkt5ihr5s5f
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
2iawmazodbz
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
t69e7bjr8kxx3h9c6nx8
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
39x8w4tl7y1 mivxx4b
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
nbhogob6a49l68vn7
16 Nov 21
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team
4:03pm
6-K
EX-99.1
me4lbra 9blm3
2 Nov 21
RepliCel Announces Dermal Injector Update
12:31pm
6-K
EX-99.1
slux82u8
14 Oct 21
51-102F3 Material Change Report
4:00pm
6-K
EX-99.1
wk7uhat5
13 Oct 21
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
12:00am
6-K
EX-99.2
tmpaa2egbl ow5
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
5ow0du2c40cesn0i8p
18 Aug 21
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
12:38pm
6-K
EX-99.4
ifvms8d2 ztj
18 Aug 21
Current report (foreign)
12:20pm